Bill Snyder Archive — Page 52 of 121

Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
April 8, 2020

Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments

Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.

Group of eight adults posing outdoors in front of leafy vegetation.
April 6, 2020

VUMC team aids development of potential antiviral drug for COVID-19

Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19.

Close-up stylized graphic displaying the words “COVID-19” and “VIRUS” over a dark digital interface with glowing lines, numbers, and circuit-like patterns.
April 2, 2020

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.

Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
March 23, 2020

Researchers developing potential coronavirus antibody therapies

Vanderbilt University Medical Center is teaming up with academic, governmental and corporate partners in an unprecedented, fast-tracked global effort to develop antibody-based treatments to protect people exposed to the 2019 novel coronavirus disease, COVID-19.

Close-up of a hand applying white powder with a small scoop over a photograph of a person's eye on a textured surface.
March 19, 2020

Blocking stress-induced relapse

Danny Winder and colleagues are teasing apart the actions of neurotransmitter receptors in a brain region linked to anxiety and addiction, with a goal of finding treatments for substance use disorders.

Head-and-shoulders portrait of a smiling bald man wearing glasses, a suit, and tie, with bookshelves in the background.
March 18, 2020

Ibuprofen and COVID-19: a doctor’s guidance

Last week, France’s health ministry urged people who have been infected by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) to avoid taking over-the- counter nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen and aspirin because they might increase the severity of the infection.